Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Takotsubo effect" in patients with ST segment elevation myocardial infarction.1 passage
• 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial.1 passage
• 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group.1 passage
• A consensus statement on lipid management after acute coronary syndrome.1 passage
• A direct comparison of decision rules for early discharge of suspected acute coronary syndromes in the era of high sensitivity troponin.1 passage
• A randomised double-blind pilot trial comparing a mean arterial pressure target of 65 mm Hg versus 72 mm Hg after out-of-hospital cardiac arrest.1 passage
• A simple risk chart for initial risk assessment of 30-day mortality in patients with cardiogenic shock from ST-elevation myocardial infarction.1 passage
• A single centre prospective cohort study addressing the effect of a rule-in/rule-out troponin algorithm on routine clinical practice.1 passage
• A-lines and B-lines in patients with acute heart failure.1 passage
• Accuracy of a diagnostic strategy combining aortic dissection detection risk score and D-dimer levels in patients with suspected acute aortic syndrome.1 passage
• Accuracy of aortic dissection detection risk score alone or with D-dimer: A systematic review and meta-analysis.1 passage
• Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.1 passage
• Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology.1 passage
• Acute aortic syndromes: a review of what we know and future considerations.1 passage
• Acute cardiorenal syndrome in acute heart failure: focus on renal replacement therapy.1 passage
• Acute coronary syndromes in insulin treated diabetics, elderly and female patients: remaining gaps in EMS activation, therapy and clinical outcomes.1 passage
• Acute diagonal-induced ST-elevation myocardial infarction and electrocardiogram-guidance in the era of primary coronary intervention: New insights into an old tool.1 passage
• Acute intraoperative effect of intravenous amiodarone on right ventricular function in patients undergoing valvular surgery.1 passage
• Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.1 passage
• Acute mesenteric ischaemia in refractory shock on veno-arterial extracorporeal membrane oxygenation.1 passage
• Acute mitral regurgitation in Takotsubo cardiomyopathy.1 passage
• Acute respiratory failure and inflammatory response after out-of-hospital cardiac arrest: results of the Post-Cardiac Arrest Syndrome (PCAS) pilot study.1 passage
• Acute type A aortic dissection: Aortic Dissection Detection Risk Score in emergency care - surgical delay because of initial misdiagnosis.1 passage
• Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarction.1 passage
• Admission plasma glucose levels within the normal to mildly impaired range and the outcome of patients with acute coronary syndrome.1 passage
• Advanced cardiovascular life support algorithm for the management of the hospitalized unresponsive patient on continuous flow left ventricular assist device support outside the intensive care unit.1 passage
• Age-specific prognostication after out-of-hospital cardiac arrest - The ethical dilemma between 'life-sustaining treatment' and 'the right to die' in the elderly.1 passage
• Allogeneic peripheral blood stem cell transplantation and accelerated atherosclerosis: An intriguing association needing targeted surveillance. Lessons from a rare case of acute anterior myocardial infarction.1 passage
• Altered mental status predicts mortality in cardiogenic shock - results from the CardShock study.1 passage
• Ambulance use, distance and outcomes in patients with suspected cardiovascular disease: a registry-based geographic information system study.1 passage
• An East-West comparison of self-care barriers in heart failure.1 passage
• An innovative lipid-lowering approach to enhance attainment of low-density lipoprotein cholesterol goals.1 passage
• An intriguing case of acute myocardial ischaemia in a patient with severe respiratory failure with veno-venous extracorporeal support.1 passage
• An observational study assessing the impact of a cardiac arrest centre on patient outcomes after out-of-hospital cardiac arrest (OHCA).1 passage
• Antithrombotic therapy before, during and after emergency angioplasty for ST elevation myocardial infarction.1 passage
• Apical Takotsubo syndrome versus anterior acute myocardial infarction: findings from the Tokyo Cardiovascular Care Unit network registry.1 passage
• Apical hypertrophic cardiomyopathy presenting as acute coronary syndrome.1 passage
• Arterial blood pressure during targeted temperature management after out-of-hospital cardiac arrest and association with brain injury and long-term cognitive function.1 passage
• Assessment of early treatment response by rapid cardiothoracic ultrasound in acute heart failure: Cardiac filling pressures, pulmonary congestion and mortality.1 passage
• Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking.1 passage
• Assessment of quality of care of patients with ST-segment elevation myocardial infarction.1 passage
• Assessment of quality performance measures for primary percutaneous coronary intervention: A report from a tertiary referral centre in Switzerland.1 passage
• Assessment of the ESC quality indicators in patients with acute myocardial infarction: a systematic review.1 passage
• Association between age and neurological outcomes in out-of-hospital cardiac arrest patients resuscitated with extracorporeal cardiopulmonary resuscitation: a nationwide multicentre observational study.1 passage
• Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes.1 passage
• Association between cardiac rhythm conversion and neurological outcome among cardiac arrest patients with initial shockable rhythm: a nationwide prospective study in Japan.1 passage
• Association between new-onset right bundle branch block and primary or secondary ventricular fibrillation in ST-segment elevation myocardial infarction.1 passage
• Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis.1 passage
• Association between β-blocker dose and cardiovascular outcomes after myocardial infarction: insights from the SWEDEHEART registry.1 passage
• Association of admission and discharge anemia status with outcomes in patients hospitalized for acute decompensated heart failure: Differences between patients with preserved and reduced ejection fraction.1 passage
• Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction.1 passage
• Association of baseline platelet count with all-cause mortality after acute myocardial infarction.1 passage
• Association of plasma interleukin-6 with infarct size, reperfusion injury, and adverse remodelling after ST-elevation myocardial infarction.1 passage
• Association of serial high sensitivity troponin T with onset of atrial fibrillation in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.1 passage
• Atrial fibrillation detected initially during acute medical illness: A systematic review.1 passage
• Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology.1 passage
• Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction.1 passage
• Awake venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock.1 passage
• B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction.1 passage
• Background and design of the ACCA-EAPCI registry on ST-segment elevation myocardial infarction of the European Society of Cardiology.1 passage
• Baseline MELD-XI score and outcome from veno-arterial extracorporeal membrane oxygenation support for acute decompensated heart failure.1 passage
• Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.1 passage
• Benefit and harm of intravenous vasodilators across the clinical profile spectrum in acute cardiogenic pulmonary oedema patients.1 passage
• Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study.1 passage
• Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis.1 passage
• Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction.1 passage
• Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction.1 passage
• Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials.1 passage
• Body mass index and acute coronary syndromes: paradox or confusion?1 passage
• CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.1 passage
• CHA1 passage
• Cancer is not associated with higher short or long-term mortality after successful resuscitation from out-of-hospital cardiac arrest when adjusting for prognostic factors.1 passage
• Cardiac arrest as an age-dependent prognosticator for long-term mortality after acute myocardial infarction: the potential impact of infarction size.1 passage
• Cardiac complications in patients hospitalised with COVID-19.1 passage
• Cardiac device troubleshooting in the intensive care unit: an educational review.1 passage
• Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.1 passage
• Cardiac involvement in critically ill patients with leptospirosis: A prospective study using myocardial deformation imaging.1 passage
• Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.1 passage
• Cardiac tamponade: an educational review.1 passage
• Cardiac troponin T elevation associated with transient global amnesia: another differential diagnosis of 'troponosis'.1 passage
• Cardiac troponin and infective endocarditis prognosis: a systematic review and meta-analysis.1 passage
• Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.1 passage
• Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarction.1 passage
• Cardiovascular biomarkers in patients with COVID-19.1 passage
• Central autonomic nervous system response to autonomic challenges is altered in patients with a previous episode of Takotsubo cardiomyopathy.1 passage
• Challenges in secondary prevention after acute myocardial infarction: A call for action.1 passage
• Change of BNP between admission and discharge after ST-elevation myocardial infarction (Killip I) improves risk prediction of heart failure, death, and recurrent myocardial infarction compared to single isolated measurement in addition to the GRACE score.1 passage
• Characteristics and outcomes associated with 30-day readmissions following acute coronary syndrome 2000-2013: the Acute Coronary Syndrome Israeli Survey.1 passage
• Characteristics of patients with false- ST-segment elevation myocardial infarction diagnoses.1 passage
• Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact?1 passage
• Classification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profile.1 passage
• Clevidipine as a therapeutic and cost-effective alternative to sodium nitroprusside in patients with acute aortic syndromes.1 passage
• Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial.1 passage
• Clinical impact of mineralocorticoid receptor antagonists treatment after acute coronary syndrome in the real world: A propensity score matching analysis.1 passage
• Clinical impact of the 2010-2012 low-end shift of high-sensitivity cardiac troponin T.1 passage
• Clinical implications of pleural effusion in patients with acute type B aortic dissection.1 passage
• Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.1 passage
• Clinical outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction according to sex and race.1 passage
• Clinical outcomes of nonagenarians with acute myocardial infarction who undergo percutaneous coronary intervention.1 passage
• Clinical outcomes of patients presenting with spontaneous coronary artery dissection versus takotsubo syndrome: a propensity score analysis.1 passage
• Clinical outcomes of patients with acute coronary syndrome and moderate or severe chronic anaemia undergoing coronary angiography or intervention.1 passage
• Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality.1 passage
• Clinical presentation of patients with prior coronary artery bypass grafting and suspected acute myocardial infarction.1 passage
• Clinical presentations and outcomes of Takotsubo syndrome in the setting of subarachnoid hemorrhage: A systematic review and meta-analysis.1 passage
• Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: the WESTCOR study.1 passage
• Clinical significance of the N-terminal pro-brain natriuretic peptide and B-type natriuretic peptide ratio in the acute phase of acute heart failure.1 passage
• Clinical value of ST-segment change after return of spontaneous cardiac arrest and emergent coronary angiography in patients with out-of-hospital cardiac arrest: Diagnostic and therapeutic importance of vasospastic angina.1 passage
• Combining therapeutic hypothermia and emergent coronary angiography in out-of-hospital cardiac arrest survivors: Optimal post-arrest care for the best patient.1 passage
• Comparative care and outcomes for acute coronary syndromes in Central and Eastern European Transitional countries: A review of the literature.1 passage
• Comparison of distinctive clinical and cardiac magnetic resonance features between ST elevation myocardial infarction patients with incomplete myocardial rupture and those with moderate to severe pericardial effusion.1 passage
• Comparison of peri and post-procedural complications in patients undergoing revascularisation of coronary artery multivessel disease by coronary artery bypass grafting or protected percutaneous coronary intervention with the Impella 2.5 device.1 passage
• Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.1 passage
• Comparison of risk prediction models in infarct-related cardiogenic shock.1 passage
• Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival.1 passage
• Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcome.1 passage
• Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization.1 passage
• Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study.1 passage
• Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: findings from the EPICOR study.1 passage
• Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group.1 passage
• Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience.1 passage
• Controlled pericardiocentesis in patients with cardiac tamponade complicating aortic dissection: experience of a centre without cardiothoracic surgery.1 passage
• Copeptin to rule out myocardial infarction in Blacks versus Caucasians.1 passage
• Coronary endothelial function and spontaneous coronary artery dissection.1 passage
• Coronary flow improvement following unsuccessful primary percutaneous coronary intervention in ST-elevation myocardial infarction with diffuse ectatic coronary artery.1 passage
• Coronary spasm and myocardial bridging: an elusive pathophysiological mechanism leading to apical ballooning syndrome?1 passage
• Coronary spasm secondary to cefuroxime injection, complicated with cardiogenic shock - a manifestation of Kounis syndrome: case report and literature review.1 passage
• Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial.1 passage
• Cost-utility of venoarterial extracorporeal membrane oxygenation in cardiogenic shock and cardiac arrest.1 passage
• Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes.1 passage
• Current knowledge and recent development on management of peripartum cardiomyopathy.1 passage
• Current perspectives on location of monitoring and length of stay following PPCI for ST elevation myocardial infarction.1 passage
• Current status and needs for changes in critical care training: the voice of the young cardiologists.1 passage
• Current status of the management and outcomes of acute aortic dissection in Japan: Analyses of nationwide Japanese Registry of All Cardiac and Vascular Diseases-Diagnostic Procedure Combination data.1 passage
• Cytotoxin-associated gene antigen-positive strains of Helicobacter pylori and recurring acute coronary syndromes.1 passage
• Data-driven point-of-care risk model in patients with acute myocardial infarction and cardiogenic shock.1 passage
• De novo and pre-existing atrial fibrillation in acute coronary syndromes: impact on prognosis and cardiovascular events in long-term follow-up.1 passage
• Deep sedation as temporary bridge to definitive treatment of ventricular arrhythmia storm.1 passage
• Development and validation of a novel prediction score for cardiac tamponade in emergency department patients with pericardial effusion.1 passage
• Development and validation of a prognostic model for survival in patients treated with venoarterial extracorporeal membrane oxygenation: the PREDICT VA-ECMO score.1 passage
• Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudy.1 passage
• Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association.1 passage
• Diagnosis of cardiogenic shock without the use of a pulmonary artery catheter.1 passage
• Diagnosis, management and mortality in acute aortic syndrome: results of the Spanish Registry of Acute Aortic Syndrome (RESA-II).1 passage
• Diagnostic Accuracy Of The Electrocardiographic Decision Support - Myocardial Ischaemia (EDS-MI) Algorithm In Detection Of Acute Coronary Occlusion.1 passage
• Diagnostic accuracy of functional, imaging and biochemical tests for patients presenting with chest pain to the emergency department: A systematic review and meta-analysis.1 passage
• Diagnostic and prognostic value of ST-segment deviation scores in suspected acute myocardial infarction.1 passage
• Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA).1 passage
• Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection.1 passage
• Diagnostic role and prognostic implications of D-dimer in different classes of acute aortic syndromes.1 passage
• Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction.1 passage
• Difference in the in-hospital prognosis between ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction with high Killip class: Data from the Japan Acute Myocardial Infarction Registry.1 passage
• Differences in measurement of high-sensitivity troponin in an on-demand and batch-wise setting.2 passages
• Differences in presentation and clinical outcomes between left or right bundle branch block and ST segment elevation in patients with acute myocardial infarction.1 passage
• Differences in symptoms, first medical contact and pre-hospital delay times between patients with ST- and non-ST-elevation myocardial infarction.1 passage
• Differential diagnosis at admission between Takotsubo cardiomyopathy and acute apical-anterior myocardial infarction in postmenopausal women.1 passage
• Differential diagnosis of a fulminant myocarditis: the pheochromocytoma crisis.1 passage
• Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.1 passage
• Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes.1 passage
• Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial.1 passage
• Does cardiac rhythm monitoring in patients with elevated troponin levels lead to changes in management?1 passage
• Does helicopter transport delay prehospital transfer for STEMI patients in rural areas? Findings from the CRAC France PCI registry.1 passage
• Doppler echocardiography for assessment of systemic vascular resistances in cardiogenic shock patients.1 passage
• Dyspnoea management in acute coronary syndrome patients treated with ticagrelor.1 passage
• Early aspirin desensitization in unstable patients with acute coronary syndrome: Short and long-term efficacy and safety.1 passage
• Early increase in serum fatty acid binding protein 4 levels in patients with acute myocardial infarction.1 passage
• Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials.1 passage
• Early invasive versus early conservative strategy in non-ST-elevation acute coronary syndrome: An outcome research study.1 passage
• Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T.1 passage
• Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited.1 passage
• Early signs of right ventricular systolic and diastolic dysfunction in acute severe respiratory failure: the importance of diastolic restrictive pattern.1 passage
• Echocardiography is useful to predict postoperative atrial fibrillation in patients undergoing isolated coronary bypass surgery: A prospective study.1 passage
• Editor's Choice - Acute Cardiovascular Care Association Position Paper on Intensive Cardiovascular Care Units: An update on their definition, structure, organisation and function.1 passage
• Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association.1 passage
• Editor's Choice - Impact of initial hospital diagnosis on mortality for acute myocardial infarction: A national cohort study.1 passage
• Editor's Choice- Call to action: Initiation of multidisciplinary care for acute heart failure begins in the Emergency Department.1 passage
• Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.1 passage
• Editor's Choice- Gender difference in prognostic impact of in-hospital bleeding after myocardial infarction - data from the SWEDEHEART registry.1 passage
• Editor's Choice- Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial.1 passage
• Editor's Choice- Impact of identifying precipitating factors on 30-day mortality in acute heart failure patients.1 passage
• Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial.1 passage
• Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction.1 passage
• Editor's Choice- Inside the cold heart: A review of therapeutic hypothermia cardioprotection.1 passage
• Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome.1 passage
• Editor's Choice- Pathophysiology, diagnosis and management of MINOCA: an update.1 passage
• Editor's Choice- Reperfusion cardiac arrhythmias and their relation to reperfusion-induced cell death.1 passage
• Editor's Choice- Sedation in the coronary intensive care unit: An adapted algorithm for critically ill cardiovascular patient.1 passage
• Editor's Choice- What do small serum creatinine changes tell us about outcomes after acute myocardial infarction?1 passage
• Editor's Choice-Acute versus subacute angiography in patients with non-ST-elevation myocardial infarction - the NONSTEMI trial phase I.1 passage
• Editor's Choice-Biomarkers of acute cardiovascular and pulmonary diseases.1 passage
• Editor's Choice-Chest pain relief in patients with acute myocardial infarction.1 passage
• Editor's Choice-Clinical impact of delirium and antipsychotic therapy: 10-Year experience from a referral coronary care unit.1 passage
• Editor's Choice-Diuretic resistance in acute heart failure.1 passage
• Editor's Choice-Effects of targeted temperature management on mortality and neurological outcome: A systematic review and meta-analysis.1 passage
• Editor's Choice-Extracorporeal life support for out-of-hospital cardiac arrest: Part of a treatment bundle.1 passage
• Editor's Choice-Is the pre-hospital ECG after out-of-hospital cardiac arrest accurate for the diagnosis of ST-elevation myocardial infarction?1 passage
• Editor's Choice-Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease.1 passage
• Editor's Choice-Progress in the chain of survival and its impact on outcomes of patients admitted to a specialized high-volume cardiac arrest center during the past two decades.1 passage
• Editor's Choice-Prospective registry of cardiac critical illness in a modern tertiary care Cardiac Intensive Care Unit.1 passage
• Editor's Choice-Recent therapeutic trials on fluid removal and vasodilation in acute heart failure.1 passage
• Editor's Choice-Sex differences in young patients with acute myocardial infarction: A VIRGO study analysis.1 passage
• Editor's Choice-The cardiovascular implications of sedatives in the cardiac intensive care unit.1 passage
• Editor's Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association.1 passage
• Editor's Choice-The role of the emergency department in the management of acute heart failure: An international perspective on education and research.1 passage
• Editor's Choice-The treatment of electrical storm: an educational review.1 passage
• Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48.1 passage
• Effect of age on the prognostic value of left ventricular function in patients with acute coronary syndrome: A prospective registry study.1 passage
• Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis.1 passage
• Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device.1 passage
• Effectiveness, safety and feasibility of an evidence-based insulin infusion protocol targeting moderate glycaemic control in intensive cardiac care units.1 passage
• Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty.1 passage
• Effects of extracorporeal cardiopulmonary resuscitation on neurological and cardiac outcome after ischaemic refractory cardiac arrest.1 passage
• Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome.1 passage
• Effects on length of stay and costs with same-day retransfer to the referring hospitals for patients with acute coronary syndrome after angiography and/or percutaneous coronary intervention.1 passage
• Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials.1 passage
• Efficacy and safety of vorapaxar for secondary prevention in low body weight in patients with atherosclerosis: analyses from the TRA 2°P-TIMI 50 Trial.1 passage
• Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy.1 passage
• Electrocardiogram changes and wall motion abnormalities in the acute phase of Tako-Tsubo syndrome.1 passage
• Electrocardiographic characteristics associated with in-hospital outcome in patients with left main acute coronary syndrome: For contriving a new risk stratification score.1 passage
• Electrocardiography changes and their significance during treatment of patients with intermediate-high and high-risk pulmonary embolism.1 passage
• Elevated admission urinary1 passage
• Emergency transcatheter aortic valve implantation in patients with severe aortic regurgitation and a left ventricle assist device: A case report and systematic review.1 passage
• Emergent transvenous cardiac pacing using ultrasound guidance: a prospective study versus the standard fluoroscopy-guided procedure.1 passage
• Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention.1 passage
• Epicardial potentials computed from the body surface potential map using inverse electrocardiography and an individualised torso model improve sensitivity for acute myocardial infarction diagnosis.1 passage
• Estimating glomerular filtration rate in acute coronary syndromes: Different equations, different mortality risk prediction.1 passage
• Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds.1 passage
• Ethnic differences in clinical outcome of patients presenting to the emergency department with chest pain.1 passage
• European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department.1 passage
• European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care.1 passage
• Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases.1 passage
• Excess mortality and guideline-indicated care following non-ST-elevation myocardial infarction.1 passage
• External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients.1 passage
• External validation of a high-sensitive troponin I algorithm for rapid evaluation of acute myocardial infarction in a Danish cohort.1 passage
• External validation of an emergency department triage algorithm for chest pain patients.1 passage
• Extracorporeal life support in cardiovascular patients with observed refractory in-hospital cardiac arrest is associated with favourable short and long-term outcomes: A propensity-matched analysis.1 passage
• Extreme QT prolongation in elderly women after non-ST elevation myocardial infarct.1 passage
• Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.1 passage
• Factors modifying performance of a novel citizen text message alert system in improving survival of out-of-hospital cardiac arrest.1 passage
• Family history of coronary artery disease is associated with acute coronary syndrome in 28,188 chest pain patients.1 passage
• Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score.1 passage
• Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: rationale and design.1 passage
• Fibrinolysis in left-sided mechanical prosthetic valve thrombosis with high INR.1 passage
• Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study.1 passage
• Field triage in the ambulance versus referral via non-percutaneous coronary intervention centre in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review.1 passage
• First case of atypical takotsubo cardiomyopathy in a bilateral lung-transplanted patient due to acute respiratory failure.1 passage
• First-in-man analysis of the i-cor assist device in patients with cardiogenic shock.1 passage
• Five-year evolution of reperfusion strategies and early mortality in patients with ST-segment elevation myocardial infarction in France.1 passage
• Five-year risk of heart failure and death following myocardial infarction with cardiogenic shock: a nationwide cohort study.1 passage
• Five-year survival after post-cardiotomy veno-arterial extracorporeal membrane oxygenation.1 passage
• Frailty and acute coronary syndrome: A structured literature review.1 passage
• Frailty is a short-term prognostic marker in acute coronary syndrome of elderly patients.1 passage
• Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.1 passage
• GRACE score predicts heart failure admission following acute coronary syndrome.1 passage
• Gender difference with the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: From pVAD Working Group.1 passage
• Gender differences in outcomes in patients with acute coronary syndrome in the current era: A review.1 passage
• Gender differences in patient and system delay for primary percutaneous coronary intervention: current trends in a Swiss ST-segment elevation myocardial infarction population.1 passage
• Gender differences in pre-event health status of young patients with acute myocardial infarction: A VIRGO study analysis.1 passage
• Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction.1 passage
• Growth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF study.1 passage
• Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy.1 passage
• Guideline-adherence regarding critical time intervals in the German Chest Pain Unit registry.1 passage
• HEART score improves efficiency of coronary computed tomography angiography in patients suspected of acute coronary syndrome in the emergency department.1 passage
• HEART score performance in Asian and Caucasian patients presenting to the emergency department with suspected acute coronary syndrome.1 passage
• Haemodynamics and vasopressor support during prolonged targeted temperature management for 48 hours after out-of-hospital cardiac arrest: a post hoc substudy of a randomised clinical trial.1 passage
• Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention.1 passage
• Heart rate at admission is a predictor of in-hospital mortality in patients with acute coronary syndromes: Results from 58 European hospitals: The European Hospital Benchmarking by Outcomes in acute coronary syndrome Processes study.1 passage
• Helmet continuous positive airway pressure vs. high flow nasal cannula oxygen in acute cardiogenic pulmonary oedema: a randomized controlled trial.1 passage
• Heterogeneous impact of body mass index on in-hospital mortality in acute heart failure syndromes: An analysis from the ATTEND Registry.1 passage
• High sensitivity cardiac troponins: Can they help in diagnosing myocardial ischaemia?1 passage
• High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causality.1 passage
• High-sensitivity cardiac troponin assays and unstable angina.1 passage
• High-sensitivity troponin and novel biomarkers for the early diagnosis of non-ST-segment elevation myocardial infarction in patients with atrial fibrillation.1 passage
• Hospitalization-related economic impact of patients with cardiogenic shock in a high-complexity reference centre.1 passage
• How is cardiac troponin released from injured myocardium?1 passage
• How to use D-dimer in acute cardiovascular care.1 passage
• Hyperglycaemia in comatose survivors of out-of-hospital cardiac arrest.1 passage
• Hypertension predicts major adverse cardiac events after discharge from the emergency department with unspecified chest pain.1 passage
• Hyponatremia at discharge is associated with adverse prognosis in acute heart failure syndromes with preserved ejection fraction: a report from the JASPER registry.1 passage
• IL-18 stimulates B-type natriuretic peptide synthesis by cardiomyocytes in vitro and its plasma levels correlate with B-type natriuretic peptide in non-overloaded acute heart failure patients.1 passage
• If worst comes to horrible - sealing an iatrogenic coronary perforation with a polytetrafluoroethylene-covered stent in a patient with aspirin intolerance.1 passage
• Impact of acute coronary syndromes on survival of dialysis patients following surgical or percutaneous coronary revascularization in the United States.1 passage
• Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.1 passage
• Impact of bleeding on mortality in patients with acute myocardial infarction complicated by cardiogenic shock.1 passage
• Impact of body temperature at admission on inhospital outcomes in patients with takotsubo syndrome: insights from the Tokyo Cardiovascular Care Unit Network Registry.1 passage
• Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial.1 passage
• Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.1 passage
• Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segment elevation myocardial infarction. FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) 2010.1 passage
• Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes.1 passage
• Impact of hospital volume of valve operations on the utilization and outcomes of surgery for patients with infective endocarditis.1 passage
• Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.1 passage
• Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock.1 passage
• Impact of mobile intensive care unit use on total ischemic time and clinical outcomes in ST-elevation myocardial infarction patients - real-world data from the Acute Coronary Syndrome Israeli Survey.1 passage
• Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.1 passage
• Impact of myocardial infarction symptom presentation on emergency response and survival.1 passage
• Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: Impact of ventricular fibrillation in STEMI patients.1 passage
• Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort study.1 passage
• Impact of patient positioning on lung ultrasound findings in acute heart failure.1 passage
• Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis.1 passage
• Impact of previous coronary artery bypass grafting in patients presenting with an acute coronary syndrome: Current trends and clinical implications.1 passage
• Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention.1 passage
• Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.1 passage
• Impact of time to cooling initiation and time to target temperature in patients treated with hypothermia after cardiac arrest.1 passage
• Impact of timing of intraaortic balloon counterpulsation on mortality in cardiogenic shock - a subanalysis of the IABP-SHOCK II trial.1 passage
• Impact of triggering event in outcomes of stress-induced (Takotsubo) cardiomyopathy.1 passage
• Implant of permanent pacemaker during acute coronary syndrome: Mortality and associated factors in the ARIAM registry.1 passage
• Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.1 passage
• Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.1 passage
• Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream".1 passage
• Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: Results from the DANAMI-3 trial.1 passage
• Importance of primary percutaneous coronary intervention for reducing mortality in ST-elevation myocardial infarction complicated by out of hospital cardiac arrest.1 passage
• Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.1 passage
• Improving 1-year mortality prediction in ACS patients using machine learning.1 passage
• Improving bystander defibrillation in out-of-hospital cardiac arrests at home.1 passage
• In the transition from fibrinolysis to primary PCI, the HERO trials help refine STEMI ECG interpretation and Q wave analysis potentially alters future management.1 passage
• In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure.1 passage
• In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism.1 passage
• In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.1 passage
• In-hospital switching from clopidogrel to prasugrel following thrombolysis for ST-elevation myocardial infarction: a 3-year single center experience.1 passage
• Incidence and characteristics of acute aortic dissection in patients with out-of-hospital cardiopulmonary arrest evaluated by non-contrast computed tomography.1 passage
• Incidence and outcome of peri-procedural cardiogenic shock: results from the international Euro Heart Survey PCI registry.1 passage
• Incidence and predictors of in-hospital non-cardiac death in patients with acute heart failure.1 passage
• Incidence and timing of serious arrhythmias after early revascularization in non ST-elevation myocardial infarction.1 passage
• Incidence of major adverse cardiac events following non-cardiac surgery.1 passage
• Incidence, clinical presentation, management, and outcome of acute pericarditis and myopericarditis.1 passage
• Incidence, determinants and prognostic relevance of cardiogenic shock in patients with Takotsubo cardiomyopathy.1 passage
• Incidence, predictors and prognosis of respiratory support in non-ST segment elevation myocardial infarction.1 passage
• Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention.1 passage
• Incidence, treatment strategies and outcomes of acute coronary syndrome with and without ongoing myocardial ischaemia: results from the CZECH-3 registry.1 passage
• Increased mortality risk in diabetic patients discharged from hospital with insulin therapy after an acute myocardial infarction: Data from the FAST-MI 2005 registry.1 passage
• Incremental costs of high intensive care utilisation in patients hospitalised with heart failure.1 passage
• Incremental value of copeptin in suspected acute myocardial infarction very early after symptom onset.1 passage
• Incremental value of heart-type fatty acid-binding protein in suspected acute myocardial infarction early after symptom onset.1 passage
• Incremental value of high-frequency QRS analysis for diagnosis and prognosis in suspected exercise-induced myocardial ischaemia.1 passage
• Inflammatory markers in ST-elevation acute myocardial infarction.1 passage
• Influence of age and shock severity on short-term survival in patients with cardiogenic shock.1 passage
• Inhaled nitric oxide has pulmonary vasodilator efficacy both in the immediate and prolonged phase of acute pulmonary embolism.1 passage
• Initial medical management in acute type A aortic dissection patients with a thrombosed false lumen in the ascending aorta combining intramural hematoma and retrograde dissection from the descending to the ascending aorta.1 passage
• Initiation of and persistence with P2Y12 inhibitors in patients with myocardial infarction according to revascularization strategy: a nationwide study.1 passage
• Inotropic therapies in heart failure and cardiogenic shock: an educational review.1 passage
• Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation.1 passage
• Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty.1 passage
• Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial.1 passage
• Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.1 passage
• Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction.1 passage
• Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.1 passage
• Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y1 passage
• Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices.1 passage
• Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention.1 passage
• Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure: a new option for critically ill patients.1 passage
• Left ventricular end-diastolic pressure predicts in-hospital outcomes in takotsubo syndrome.1 passage
• Life-threatening arrhythmias in anterior ST-segment elevation myocardial infarction patients treated by percutaneous coronary intervention: adverse impact of morphine.1 passage
• Long term survival after early unloading with Impella CP1 passage
• Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.1 passage
• Long-term clinical outcomes in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock due to acute pump failure.1 passage
• Long-term effects of a standardized feedback-driven quality improvement program for timely reperfusion therapy in regional STEMI care networks.1 passage
• Long-term outcome of patients after out-of-hospital cardiac arrest in relation to treatment: a single-centre study.1 passage
• Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.1 passage
• Long-term prognostic value of delirium in elderly patients with acute cardiac diseases admitted to two cardiac intensive care units: a prospective study (DELIRIUM CORDIS).1 passage
• Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.1 passage
• Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study.1 passage
• Low prevalence of diabetes mellitus in patients with Takotsubo syndrome: A plausible 'protective' effect with pathophysiologic connotations.1 passage
• MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes.1 passage
• MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.1 passage
• Machine learning with D-dimer in the risk stratification for pulmonary embolism: a derivation and internal validation study.1 passage
• Management of EMS on-scene time during advanced life support in out-of-hospital cardiac arrest: a retrospective observational trial.1 passage
• Management of cardiogenic shock complicating acute myocardial infarction.1 passage
• Management of myocardial infarction in the elderly. Insights from Spanish Minimum Basic Data Set.1 passage
• Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO.1 passage
• Mechanical ventilation at the time of heart transplantation and associations with clinical outcomes.1 passage
• Medical treatment options for COVID-19.1 passage
• Medical treatment or revascularisation as the best approach for spontaneous coronary artery dissection: A systematic review and meta-analysis.1 passage
• Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic.1 passage
• Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study.1 passage
• Mitochondrial dysfunction in adults after out-of-hospital cardiac arrest.1 passage
• Mode of admission and its effect on adherence to reperfusion therapy guidelines in Belgian STEMI patients.1 passage
• Monitoring of left ventricular assist device implantation and set-up with miniaturized transoesophageal echocardiography: Initial experience at La Pitié-Salpêtrière Hospital and possible application fields.1 passage
• Mortality and missed opportunities along the pathway of care for ST-elevation myocardial infarction: a national cohort study.1 passage
• Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure.1 passage
• Mortality risk stratification using artificial intelligence-augmented electrocardiogram in cardiac intensive care unit patients.1 passage
• Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.1 passage
• Multisite vascular disease in acute coronary syndromes: increased in-hospital mortality and no improvement over time.1 passage
• Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.1 passage
• N-terminal pro-B-type natriuretic peptide is associated with aortic stiffness in patients presenting with acute myocardial infarction.1 passage
• N-terminal pro-brain natriuretic peptide and high-sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill patients.1 passage
• National trends in coronary intensive care unit admissions, resource utilization, and outcomes.1 passage
• Nationwide trends in use and timeliness of diagnostic coronary angiography in acute coronary syndromes from 2005 to 2011: Does distance to invasive heart centres matter?1 passage
• New holosystolic murmur after acute myocardial infarction.1 passage
• New or presumed new left bundle branch block in patients with suspected ST-elevation myocardial infarction.1 passage
• Non-ST elevation acute coronary syndromes: timing and selection of early invasive management, ECG monitoring need, DAPT duration, pathogenesis of recurrence and beware of delirium in the intensive/acute cardiac care unit!1 passage
• Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.1 passage
• Non-occlusive mesenteric ischaemia in out of hospital cardiac arrest survivors.1 passage
• Novel device-based therapies to improve outcome in ST-segment elevation myocardial infarction.1 passage
• Obesity and cardiovascular outcomes: a review.1 passage
• Obesity paradox disappears in coronary artery bypass graft patients during 20-year follow-up.1 passage
• Octogenarian women with acute coronary syndrome present frailty and readmissions more frequently than men.1 passage
• On versus off-hour care of patients with acute coronary syndrome and persistent ST-segment elevation in certified German chest pain units.1 passage
• Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns.1 passage
• Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial.1 passage
• Organization of intensive cardiac care units in Europe: Results of a multinational survey.1 passage
• Out-of-hospital cardiac arrest survivors sent for emergency angiography: a clinical score for predicting acute myocardial infarction.1 passage
• Outcome after cardiopulmonary resuscitation in patients with congenital heart disease.1 passage
• Outcome of inter-hospital transfer versus direct admission for primary percutaneous coronary intervention: An observational study of 25,315 patients with ST-elevation myocardial infarction from the London Heart Attack Group.1 passage
• Outcome of patients with different clinical presentations of high-risk pulmonary embolism.1 passage
• Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy.1 passage
• Outcomes following primary percutaneous coronary intervention in the setting of cardiac arrest: a registry database study.1 passage
• Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.1 passage
• Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock.1 passage
• Outcomes in patients with acute myocardial infarction and history of illicit drug use: a French nationwide analysis.1 passage
• Outcomes of early and reversible renal impairment in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.1 passage
• Outcomes of medically managed patients with myocardial infarction.1 passage
• Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial.1 passage
• Past, present, and future of mortality risk scores in the contemporary cardiac intensive care unit.1 passage
• Patient characteristics and predictors of mortality associated with pericardial decompression syndrome: a comprehensive analysis of published cases.1 passage
• Patient delay in patients with ST-elevation myocardial infarction: Time patterns and predictors for a prolonged delay.1 passage
• Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.1 passage
• Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.1 passage
• Percutaneous balloon atrial septostomy on top of venoarterial extracorporeal membrane oxygenation results in safe and effective left heart decompression.1 passage
• Percutaneous coronary intervention of an iatrogenic occlusion of the circumflex coronary artery after mitral valve replacement.1 passage
• Percutaneous coronary intervention under temporary peripheral veno-arterial extracorporeal membrane oxygenation.1 passage
• Percutaneous extracorporeal membrane oxygenation in electrical storm: five case reports addressing efficacy, transferring allowance or radiofrequency ablation support.1 passage
• Performance of the European Society of Cardiology 0/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin: Systematic review and meta-analysis.1 passage
• Pericardial decompression syndrome: a rare but potentially fatal complication of pericardial drainage to be recognized and prevented.1 passage
• Permanent junctional reciprocating tachycardia: a rare, but not to be missed, cause of cardiogenic shock in adults.1 passage
• Plasma T-cadherin negatively associates with coronary lesion severity and acute coronary syndrome.1 passage
• Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.1 passage
• Plasma volume status predicts prognosis in patients with acute heart failure syndromes.1 passage
• Platelet counts on admission affect coronary flow, myocardial perfusion and left ventricular systolic function after primary percutaneous coronary intervention.1 passage
• Pneumonia and inflammation in acute decompensated heart failure: a registry-based analysis of 1939 patients.1 passage
• Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome.1 passage
• Population-based incidence and outcomes of acute aortic dissection in Japan.1 passage
• Postoperative takotsubo cardiomyopathy: an illustration of the electrocardiographic features that raise suspicion for takotsubo.1 passage
• Potential of unenhanced computed tomography as a screening tool for acute aortic syndromes.1 passage
• Practical considerations for cangrelor use in patients with acute coronary syndromes.1 passage
• Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI.1 passage
• Pre-hospital heparin use for ST-elevation myocardial infarction is safe and improves angiographic outcomes.1 passage
• Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC.1 passage
• Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study.1 passage
• Predicting mortality in cardiac care unit patients: external validation of the Mayo cardiac intensive care unit admission risk score.1 passage
• Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers.1 passage
• Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score.1 passage
• Prediction of right heart failure after left ventricular assist implantation: external validation of the EUROMACS right-sided heart failure risk score.1 passage
• Predictive ability of bleeding risk scores in the routine clinical practice.1 passage
• Predictive factors of death associated with infective endocarditis in adult patients with congenital heart disease.1 passage
• Predictive impact on medium-term mortality of hematological parameters in Acute Coronary Syndromes: added value on top of GRACE risk score.1 passage
• Predictive value of routine point-of-care cardiac troponin T measurement for prehospital diagnosis and risk-stratification in patients with suspected acute myocardial infarction.1 passage
• Predictors and prognosis of delirium among older subjects in cardiac intensive care unit: focus on potentially preventable forms.1 passage
• Predictors of acute kidney injury in patients admitted with ST-elevation myocardial infarction - results from the Bremen STEMI-Registry.1 passage
• Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study.1 passage
• Predictors of permanent pacemaker requirement after cardiac surgery for infective endocarditis.1 passage
• Predictors of subsequent myocardial infarction, stroke, and death in stable post-myocardial infarction patients: A nationwide cohort study.1 passage
• Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.1 passage
• Prehospital cardiopulmonary resuscitation duration and neurological outcome after adult out-of-hospital cardiac arrest by location of arrest.1 passage
• Prehospital study of survival outcomes from out-of-hospital cardiac arrest in ST-elevation myocardial infarction in Queensland, Australia (the PRAISE study).1 passage
• Prehospital triage of patients suffering severe dyspnoea using N-terminal pro-brain natriuretic peptide, the PreBNP trial: a randomised controlled clinical trial.1 passage
• Pretreatment with aspirin in acute coronary syndromes: Lessons from the ACUITY and HORIZONS-AMI trials.1 passage
• Prevalence and characteristics of coronary microvascular dysfunction among chest pain patients in the emergency department.1 passage
• Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy.1 passage
• Prevalence of spontaneous coronary artery dissection in patients with acute coronary syndrome.1 passage
• Prognosis following acute coronary syndromes according to prior coronary artery bypass grafting: Meta-analysis.1 passage
• Prognostic comparison between creatinine-based glomerular filtration rate formulas for the prediction of 10-year outcome in patients with non-ST elevation acute coronary syndrome treated by percutaneous coronary intervention.1 passage
• Prognostic effects of arterial carbon dioxide levels in patients hospitalized into the cardiac intensive care unit for acute heart failure.1 passage
• Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel.1 passage
• Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of an 11-year all-comers registry.1 passage
• Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry.1 passage
• Prognostic impact of non-culprit chronic total occlusion over time in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.1 passage
• Prognostic impact of percutaneous coronary intervention in octogenarians with non-ST elevation myocardial infarction: A report from SWEDEHEART.1 passage
• Prognostic implications of fluid balance in ST elevation myocardial infarction complicated by cardiogenic shock.1 passage
• Prognostic implications of microcirculatory perfusion versus macrocirculatory perfusion in cardiogenic shock: a CULPRIT-SHOCK substudy.1 passage
• Prognostic importance of culprit lesion location in cardiogenic shock due to myocardial infarction.1 passage
• Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.1 passage
• Prognostic relevance of GRACE risk score in Takotsubo syndrome.1 passage
• Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience.1 passage
• Prognostic role of plasma galectin-3 levels in acute coronary syndrome.1 passage
• Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction.1 passage
• Prognostic usefulness of an age-adapted equation for renal function assessment in older patients with acute coronary syndrome.1 passage
• Prognostic value of automated pupillometry: an unselected cohort from a cardiac intensive care unit.1 passage
• Prognostic value of base excess as indicator of acid-base balance in acute heart failure.1 passage
• Prognostic value of decreased peripheral congestion detected by Bioelectrical Impedance Vector Analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure.1 passage
• Prognostic value of depressed cardiac index after STEMI: a phase-contrast magnetic resonance study.1 passage
• Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department.1 passage
• Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease.1 passage
• Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromes.1 passage
• Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study.1 passage
• Prognostic value of shock index in patients admitted with non-ST-segment elevation myocardial infarction: the ARIC study community surveillance.1 passage
• Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study.1 passage
• Proposal for a standardized discharge letter after hospital stay for acute myocardial infarction.1 passage
• Prospective assessment of a palliative care tool to predict one-year mortality in patients with acute coronary syndrome.1 passage
• Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure.1 passage
• Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association.1 passage
• Quantification of pleural effusions on thoracic ultrasound in acute heart failure.1 passage
• RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction.1 passage
• Radial artery access is associated with lower mortality in patients undergoing primary PCI: a report from the SWEDEHEART registry.1 passage
• Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART.1 passage
• Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.1 passage
• Recognition of acute myocardial infarction caused by spontaneous coronary artery dissection of first septal perforator.1 passage
• Recurrence of angina after ST-segment elevation myocardial infarction: the role of coronary microvascular obstruction.1 passage
• Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study.1 passage
• Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.1 passage
• Relation of subclinical serum creatinine elevation to adverse in-hospital outcomes among myocardial infarction patients.1 passage
• Relation of vascular dilator function and cardiac autonomic function with coronary angiography findings in patients with non-ST segment elevation acute coronary syndrome.1 passage
• Relations among depressive symptoms, electrocardiographic hypertrophy, and cardiac events in non-ST elevation acute coronary syndrome patients.1 passage
• Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study.1 passage
• Relationship between treatment delay and type of reperfusion therapy and mechanical complications of acute myocardial infarction.1 passage
• Relationship of renal insufficiency and clinical features or comorbidities with clinical outcome in patients hospitalised for acute heart failure syndromes.1 passage
• Relative survival and excess mortality following primary percutaneous coronary intervention for ST-elevation myocardial infarction.1 passage
• Release of mitochondrial DNA is associated with mortality in severe acute heart failure.1 passage
• Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trials.1 passage
• Renal dysfunction indicative of outcomes in hospitalized patients with takotsubo syndrome.1 passage
• Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome.1 passage
• Renal function and outcome of patients with non-valvular atrial fibrillation.1 passage
• Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention--is it necessary?1 passage
• Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging.1 passage
• Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary.1 passage
• Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion.1 passage
• Respiratory management in severe acute respiratory syndrome coronavirus 2 infection.1 passage
• Resuscitation outcomes of reproductive-age females who experienced out-of-hospital cardiac arrest.1 passage
• Revascularisation in older adult patients with non-ST-segment elevation acute coronary syndrome: effect and impact on 6-month mortality.1 passage
• Revisiting the lipid paradox in ST-elevation myocardial infarction in the Chinese population: findings from the CCC-ACS project.1 passage
• Right bundle branch block in patients with suspected myocardial infarction.1 passage
• Right ventricular function and iron deficiency in acute heart failure.1 passage
• Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.1 passage
• Risk assessment for infected endocarditis in1 passage
• Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.1 passage
• Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP).1 passage
• Risk stratification in normotensive acute pulmonary embolism patients: focus on the intermediate-high risk subgroup.1 passage
• Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review.1 passage
• Role and importance of ultrasound lung comets in acute cardiac care.1 passage
• Role of coronary angiography in patients with a non-diagnostic electrocardiogram following out of hospital cardiac arrest: Rationale and design of the multicentre randomized controlled COUPE trial.1 passage
• Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: Evidence from the Portuguese nationwide registry.1 passage
• Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction.1 passage
• Role of primary care physicians in treating patients with ST-segment elevation myocardial infarction located in remote areas (from the REseau Nord-Alpin des Urgences [RENAU], Network).1 passage
• ST-segment elevation in V1-V4 in acute pulmonary embolism: a case presentation and review of literature.1 passage
• ST-segment resolution with bivalirudin versus heparin and routine glycoprotein IIb/IIIa inhibitors started in the ambulance in ST-segment elevation myocardial infarction patients transported for primary percutaneous coronary intervention: The EUROMAX ST-segment resolution substudy.1 passage
• Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial.1 passage
• Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries.1 passage
• Safety of dexmedetomidine in the cardiac intensive care unit.1 passage
• Safety of therapeutic hypothermia combined with primary percutaneous coronary intervention after out-of-hospital cardiac arrest.1 passage
• Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network.1 passage
• Secondary forms of Takotsubo cardiomyopathy: A whole different prognosis.1 passage
• Serial hemodynamic measurements in post-cardiac arrest cardiogenic shock treated with therapeutic hypothermia.1 passage
• Serial high-sensitivity cardiac troponin T measurements to rule out acute myocardial infarction and a single high baseline measurement for swift rule-in: A systematic review and meta-analysis.1 passage
• Serum cholinesterase as a prognostic biomarker for acute heart failure.1 passage
• Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.1 passage
• Serum neprilysin and the risk of death in patients with out-of-hospital cardiac arrest of non-traumatic origin.1 passage
• Serum potassium level on hospital arrival and survival after out-of-hospital cardiac arrest: The CRITICAL study in Osaka, Japan.1 passage
• Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36.1 passage
• Severe Torsades de Pointes with acquired QT prolongation.1 passage
• Severe obstructive sleep apnea is associated with coronary microvascular dysfunction and obstruction in patients with ST-elevation myocardial infarction.1 passage
• Sex differences in crude mortality rates and predictive value of intensive care unit-based scores when applied to the cardiac intensive care unit.1 passage
• Sex differences in health outcomes at one year following acute myocardial infarction: A report from the China Patient-Centered Evaluative Assessment of Cardiac Events prospective acute myocardial infarction study.1 passage
• Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation.1 passage
• Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial.1 passage
• Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention.1 passage
• Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.1 passage
• Short-term prognostic effect of prior cerebrovascular and peripheral artery disease in patients with acute coronary syndrome: Can we do better?1 passage
• Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.1 passage
• Smoking is the dominating modifiable risk factor in younger patients with STEMI.1 passage
• Spontaneous coronary artery dissection in old patients: clinical features, angiographic findings, management and outcome.1 passage
• Spontaneous coronary artery dissection: Acute findings on coronary computed tomography angiography.1 passage
• Spontaneous coronary artery dissection: challenges of coronary computed tomography angiography.1 passage
• Spontaneous coronary artery rupture presenting as an acute coronary syndrome evolved in pseudoaneurysm and cardiac tamponade: Case report and literature review.1 passage
• Stent thrombosis in a patient with high on-treatment platelet reactivity despite ticagrelor treatment.1 passage
• Stress (Tako-tsubo) cardiomyopathy in critically-ill patients.1 passage
• Striking the balance in admissions with non-ST-segment elevation myocardial infarction requiring advanced respiratory support.1 passage
• Subarachnoid haemorrhage mimicking a STEMI.1 passage
• Sudden cardiac death as a presentation of anomalous origin of the left coronary artery from pulmonary artery in a young adult.1 passage
• Superiority of wall motion score index over left ventricle ejection fraction in predicting cardiovascular events after an acute myocardial infarction.1 passage
• Surgical management of an anomalous right coronary artery.1 passage
• Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score.1 passage
• Survival of patients with and without diabetes following out-of-hospital cardiac arrest: A nationwide Danish study.1 passage
• Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.1 passage
• Systematic investment in the delivery of guideline-coherent therapy reduces mortality and overall costs in patients with ST-elevation myocardial infarction: Results from the Stent for Life economic model for Romania, Portugal, Basque Country and Kemerovo region.1 passage
• Systematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes.1 passage
• Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure.1 passage
• Tako-tsubo cardiomyopathy triggered by multiple shocks in electrical storm.1 passage
• Takotsubo cardiomyopathy after acute myocardial infarction: An unusual case of possible association.1 passage
• Targeting elevated left ventricular end-diastolic pressure following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction - a phase one safety and feasibility study.1 passage
• Temporal trends in patient characteristics, presumed causes, and outcomes following cardiogenic shock between 2005 and 2017: a Danish registry-based cohort study.1 passage
• Temporal trends in the use of reperfusion therapy and outcomes in elderly patients with first ST elevation myocardial infarction.1 passage
• Ten thousand kilometre transfer of cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation for emergency heart transplantation: Cooperation between Reunion Island and Metropolitan France.1 passage
• The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries.1 passage
• The 9p21 Rs 1333040 polymorphism is associated with coronary microvascular obstruction in ST-segment elevation myocardial infarction treated by primary angioplasty.1 passage
• The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions.1 passage
• The CRAS-EAHFE study: Characteristics and prognosis of acute heart failure episodes with cardiorenal-anaemia syndrome at the emergency department.1 passage
• The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department.1 passage
• The HEART score for early rule out of acute coronary syndromes in the emergency department: a systematic review and meta-analysis.1 passage
• The HEART score in the era of the European Society of Cardiology 0/1-hour algorithm.1 passage
• The addition of echocardiographic parameters to PESI risk score improves mortality prediction in patients with acute pulmonary embolism: PESI-Echo score.1 passage
• The association between cardiac intensive care unit mechanical ventilation volumes and in-hospital mortality.1 passage
• The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.1 passage
• The association of anaemia and high-sensitivity cardiac troponin and its effect on diagnosing myocardial infarction.1 passage
• The association of diabetes and admission blood glucose with 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock.1 passage
• The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause - aims, function and structure: Position paper of the Association for Acute CardioVascular Care of the European Society of Cardiology (AVCV), European Association of Percutaneous Coronary Interventions (EAPCI), European Heart Rhythm Association (EHRA), European Resuscitation Council (ERC), European Society for Emergency Medicine (EUSEM) and European Society of Intensive Care Med1 passage
• The complement lectin pathway protein MAp19 and out-of-hospital cardiac arrest: Insights from two randomized clinical trials.1 passage
• The correlation between the amplitude of Osborn wave and core body temperature.1 passage
• The dancing heart.1 passage
• The effect of adaptive servo-ventilation on dyspnoea, haemodynamic parameters and plasma catecholamine concentrations in acute cardiogenic pulmonary oedema.1 passage
• The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial.1 passage
• The effects of intravenous insulin infusions on early mortality for patients with acute coronary syndromes who present with hyperglycaemia: A matched propensity analysis using data from the MINAP database 2008-2012.1 passage
• The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials.1 passage
• The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation.1 passage
• The impact of airway strategy on the patient outcome after out-of-hospital cardiac arrest: A propensity score matched analysis.1 passage
• The impact of delirium on outcomes in acute, non-intubated cardiac patients.1 passage
• The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study.1 passage
• The importance of β2-agonists in myocardial infarction: Findings from the Eastern Danish Heart Registry.1 passage
• The influence of chronic kidney disease and age on revascularization rates and outcomes in acute myocardial infarction - a cohort study.1 passage
• The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.1 passage
• The peak levels of highly sensitive troponin I predicts in-hospital mortality in COVID-19 patients with cardiac injury: a retrospective study.1 passage
• The prognostic effect of known and newly detected type 2 diabetes in patients with acute coronary syndrome.1 passage
• The prognostic impact of the uric acid level in patients who require cardiovascular intensive care - is serum uric acid a surrogate biomarker for critical patients in the non-surgical intensive care unit?1 passage
• The role of perioperative cardiorespiratory support in post infarction ventricular septal rupture-related cardiogenic shock.1 passage
• The use and impact of 12-lead electrocardiograms in acute stroke patients: A systematic review.1 passage
• The use of antiplatelet agents after an acute coronary syndrome in a large community Italian setting of more than 12 million subjects.1 passage
• The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure.1 passage
• The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association.1 passage
• The value of predischarge exercise ECG testing in chest pain patients in the era of high-sensitivity troponins.1 passage
• The value of urinary sodium assessment in acute heart failure.1 passage
• Therapeutic application of contrast ultrasound in ST elevation myocardial infarction: Role in coronary thrombosis and microvascular obstruction.1 passage
• Thrombotic thrombocytopenic purpura presenting as a severe peripartum cardiogenic shock: Role of myocardial biopsy and assist device for diagnosis and resuscitation.1 passage
• Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort.1 passage
• Thrombus aspiration in non-ST-elevation myocardial infarction - 12-month clinical outcome of the randomised TATORT-NSTEMI trial.1 passage
• Thyroid-stimulating hormone and adverse left ventricular remodeling following ST-segment elevation myocardial infarction.1 passage
• Time course of coronary flow capacity impairment in ST-segment elevation myocardial infarction.1 passage
• Timing positive-pressure ventilation during chest compression: the key to improving the thoracic pump?1 passage
• Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients.1 passage
• Transcatheter closure of a traumatic ventricular septum defect resulting from a stab wound.1 passage
• Transitioning from a coronary to a critical cardiovascular care unit: trends over the past three decades.1 passage
• Treatment of patients with myocardial infarction depends on history of cancer.1 passage
• Treatment strategies for post-infarction left ventricular free-wall rupture.1 passage
• Trends in clinical outcomes and survival following prehospital thrombolytic therapy given by ambulance clinicians for ST-elevation myocardial infarction in rural sub-arctic Norway.1 passage
• Trends in mortality, co-morbidity and treatment after acute myocardial infarction in patients with rheumatoid arthritis 1998-2013.1 passage
• Triggering of acute coronary occlusion by episodes of anger.1 passage
• Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis.1 passage
• Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial.1 passage
• Type III Kounis syndrome after administration of an echocardiography contrast agent.1 passage
• Uncommon cause of intracardiac thrombus.1 passage
• Uncontrolled daily pulmonary oedema due to severe mitral regurgitation emergently and effectively corrected by Mitraclip® implantation.1 passage
• Under-the-counter acquired acute coronary syndrome: Methaemoglobinaemia.1 passage
• Undetectable high-sensitivity troponin in combination with clinical assessment for risk stratification of patients with chest pain and normal troponin at hospital arrival.1 passage
• Use of copeptin for rapid rule-out of acute myocardial infarction.1 passage
• Use of copeptin in emergency patients with cardiac chief complaints.1 passage
• Use of hospital resources in the care of patients with intermediate risk pulmonary embolism.1 passage
• Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.1 passage
• Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.1 passage
• Usefulness of delta troponin for diagnosis and prognosis assessment of non-ST-segment elevation acute chest pain.1 passage
• Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials.1 passage
• Utility of shock index in 24,636 patients presenting with acute coronary syndrome.1 passage
• Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.1 passage
• Validation of the diagnostic utility of D-dimer measurement in patients with acute aortic syndrome.1 passage
• Value of syncope in patients with high-to-intermediate risk pulmonary artery embolism.1 passage
• Venoarterial extracorporeal membrane oxygenation decannulation using the novel Manta vascular closure device.1 passage
• Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial.1 passage
• Vulnerability to cardiac arrest in patients with ST elevation myocardial infarction: Is it time or patient dependent? Results from a nationwide observational study.1 passage
• Walking the tightrope: Using quantitative Doppler echocardiography to optimize ventricular filling pressures in patients hospitalized for acute heart failure.1 passage
• Weekend effect in acute coronary syndrome: A meta-analysis of observational studies.1 passage
• What to do when you question cardiac troponin values.1 passage
• Which echocardiographic parameters improve the risk prediction for peri-operative outcomes in patients undergoing coronary bypass surgery: a prospective study.1 passage
• White blood cell and platelet count as adjuncts to standard clinical evaluation for risk assessment in patients at low probability of acute aortic syndrome.1 passage
• Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?1 passage
• Women have a worse prognosis and undergo fewer coronary angiographies after out-of-hospital cardiac arrest than men.1 passage